FindTrial
Sign In

Application observation of the Edwards ClearSight for non-invasive, continuous blood pressure measurement during anaesthesia initiation in cardiosurgical patients compared to conventional invasive arterial blood pressure measurement.

Application observation of the Edwards ClearSight for non-invasive, continuous blood pressure measurement during anaesthesia initiation in cardiosurgical patients compared to conventional invasive arterial blood pressure measurement.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00021747
Enrollment
50
Registered
2020-05-18
Start date
2017-02-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I95.9

Interventions

Group 1: invasive arterial blodd pressure Monitoring and non-invasive arterial bloodpressure Monitoring via ClearSight on the same hand.

Sponsors

Klinik für Anästhesiologie und IntensivmedizinMedizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: cardiac surgery

Exclusion criteria

Exclusion criteria: atrial fibrillation, Allen-test positive, LVAD

Design outcomes

Primary

MeasureTime frame
Deviations in the minute-recorded blood pressure values in mmHg of non-invasive for invasive blood pressure measurement during a recording period for up to 30 minutes. Statistical analysis.—

Countries

Germany

Contacts

Public ContactPaul Frank

Klinik für Anästhesiologie und IntensivmedizinMedizinische Hochschule Hannover

frank.paul@mh-hannover.de0511-5322294

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026